yet. The occurrence of false positives in the latex test does not, we know, imply a greater degree of sensitivityrather, it seems to be due to some random factor not yet identified. Goldin (1962) encountered two false positives in his 69 cases. The Ortho Research Foundation (1961) differ from us in their much bigger series. Their latex testing gave 2.09% false-negative and 0.14% false-positive reactions. Conversely, their frog tests gave values of 0.50% and 1.51% respectively.
It is clearly necessary for the clinicians who request tests for pregnancy to agree with the pathologists performing these tests about the limits of accuracy that should be acceptable.
So far as the laboratory is concerned there is much to recommend a tube test which is of approximately equal effectiveness to the more laborious biological tests. However, our limited experience shows that if the latex test is adopted, an appreciable number of false-positive results must be expected, a situation which hitherto has not had to be considered.
We are reluctantly unable to recommend the latex test to our clinical colleagues unless they are prepared to accept the possible consequences of the false-positive results.
There is one aspect of the latex test which may, however, be used to advantage, even though it is not used for pregnancy diagnosis. To confirm the diagnosis of chorionepithelioma and other moles it is usual to carry out a quantitative biological test with urine dilutions. The quantitative Hogben test (Hobson, 1952) uses six toads and is therefore wasteful of animals and time. We believe that the latex test may be valuable here, but have not had the opportunity to try it. Summary Two methods of testing urine for pregnancy are compared. One is a recently introduced sensitized latex particle precipitation test, and this is compared with the widely used Hogben test-a biological test using Xenopus laevis female frogs.
Early-morning urine samples from 233 women were examined by the two methods. A number of reports have been published in the past few years which note an association between ankylosing spondylitis and inflammatory diseases of the bowel. Many of these reports are of patients who, in addition to ankylosing spondylitis, had either Crohn's disease or ulcerative colitis. In one series of 177 male patients Romanus (1953) found that three had ulcerative colitis, and Steinberg and Storey (1957) reported six cases, all with ankylosing spondylitis, of whom four had ulcerative colitis, one had Crohn's disease, and one had both Crohn's disease and ulcerative colitis. Among 220 cases of ankylosing spondylitis, Wilkinson and Bywaters (1958) described four with ulcerative colitis and one with Crohn's disease; and Fernandez-Herlihy (1959) , in a review of 555 cases of ulcerative colitis, found 28 patients with ankylosing spondylitis. In a study of 13,352 patients who had received radiotherapy for ankylosing spondylitis an apparent excess of deaths ascribed to ulcerative colitis was found (Court Brown and Doll, 1957, and personal communication) . Thus up to December, 1955, 13 Diagnosis of the bowel lesion was based on history, radiological evidence, sigmoidoscopic examination, and, where possible, histological studies. The radiological changes included evidence of ulceration, shortening, and narrowing in disease of the colon; and of inflammation, ulceration, and fistula formation in small-bowel disease. In no case was chronic inflammatory bowel disease diagnosed without such radiological evidence or, alternatively, the finding of characteristic histological changes.
Results
Of the patients in group A presenting with ankylosing spondylitis, 20 gave a history of diarrhoea or of unex-. plained loss of weight. Five of these patients had already attended other hospitals, where an acceptable diagnosis of ulcerative colitis had been made. The remaining cases were investigated by us and nine were found to have chronic inflammatory bowel disease. In addition, the case-notes of four patients in this group who had died of ulcerative colitis were obtained and critically reviewed. In the small subgroup of 67 patients who were routinely subjected to a barium-meal and follow-through examination two new cases of small-bowel disease were discovered. Both these cases were remarkable in that they were completely asymptomatic.
The 170 patients in group B in whom a diagnosis of ulcerative colitis or of Crohn's disease had been made were recalled to a special clinic and questioned about rheumatic symptoms in themselves or in their families. The x-ray films of their previous barium follow-through examinations were re-examined for evidence of ankylosing spondylitis and, where necessary, further views of the sacro-iliac joints were obtained. Five patients were found who showed radiological changes in the sacro-iliac joints. Four of these had the typical bilateral changes of ankylosing spondylitis. In the fifth patient radiological changes were restricted to the left side, and, since a diagnosis of ankylosing spondylitis was uncertain, this patient was omitted from the present series.
Details of the 24 cases with both ankylosing spondylitis and chronic inflammatory bowel disease are summarized in Table I .
In the two groups of patients eight families were found where at least one member had ankylosing spondylitis, and a hospital diagnosis of ulcerative colitis or Crohn's disease had been made in another member. The data for these families are summarized in Table II. Discussion The occurrence of two relatively uncommon diseases in one patient may be due to chance or to some aetiological factor common to both diseases. The incidence of ankylosing spondylitis in the general population has been estimated by West (1949) as 0.5 per 1,000. Houghton and Naish (1958) estimated the frequency of ulcerative colitis as 0.85 per 1,000 and of Crohn's disease as 0.14 per 1,000. In contrast, of the 560 patients in group A who were interviewed, 16 were found to have ulcerative colitis and four Crohn's disease, an incidence of 18.38 and 4.58 per 1,000 respectively. Thus the total incidence of chronic inflammatory bowel disease in this group was at least 22.96 per 1,000. This is much greater than the expected rate should association with ankylosing spondylitis be due solely to chance.
In their study of 13,352 patients with ankylosing spondylitis, Court Brown and Doll (1957) noted that 13 deaths ascribed to ulcerative colitis had occurred up to the end of 1955, whereas the expected number was 0.65. By November, 1962, the number of deaths had risen to at least 22-a minimal figure, as the follow-up is as yet incomplete. This is probably 15 times the number which might have been expected in the general population and is much greater than could reasonably be attributed to chance. In addition, in the same group of patients ulcerative colitis is mentioned as an associated cause of death in eight more cases. In a study of ankylosing spondylitis among the relatives of patients with the disease Bldcourt et al. (1961) found that the incidence was 22.6 times higher than among the relatives of normal control subjects. The occurrence of more than one case of ankylosing spondylitis in a family is thus not uncommon. Various authors have reported familial cases of ulcerative colitis and the incidence appears to be taken as between 0.5 and 7%, although Paulley (1950) described a series of 173 cases and found a familial incidence of 11.3%. Examples of familial Crohn's disease are much less common, but in his review of 298 cases Crohn (1949) described eight familial cases. In Table II we summarize the findings in eight families where one or more members had ankylosing spondylitis and another member had either ulcerative colitis or Crohn's disease. A number of cases have already been reported in which chronic inflammatory bowel disease has occurred with ankylosing spondylitis in the same individual, but this would appear to be the first occasion on which these diseases have been described in different members of the same family.
The occurrence of these relatively uncommon disorders in the same individual suggests the presence of related aetiological mechanisms, and the familial occurrence suggests either an inherited predisposition or the operation of an aetiological factor in the family environment. Although the influence of environmental factors cannot be excluded the importance of inherited predisposition appears to be established. The data at our disposal are incomplete and it is not possible to define the mode of inheritance. Hersh et al. (1950) The factors which determine whether a predisposed individual develops ankylosing spondylitis, Crohn's disease, or ulcerative colitis, or these diseases in association, are quite unknown; as are the factors which determine the order in which the associated diseases may appear.
Summary
The association of ankylosing spondylitis with ulcerative colitis and Crohn's disease is described. Of 870 patients with ankylosing spondylitis, 16 were found to have ulcerative colitis and four to have Crohn's disease. Four cases of ankylosing spondylitis were found among 170 patients with ulcerative colitis or Crohn's disease. The limitations of the methods of study make it likely that the real coincidence of ankylosing spondylitis with chronic inflammatory intestinal disease is even higher.
Attention is drawn to the relatively higher incidence of intestinal disease in females with ankylosing spondylitis. The occurrence of ankylosing spondylitis and intestinal disease in different members of the same family is described and discussed.
We (Dorsey, 1936; Wright and Littauer, 1937) or intramuscularly (Ejrup, 1956; Jost and Jochum, 1959) . With these large doses tachycardia, epigastric pain, nausea, vomiting, and other unpleasant side-effects often occurred. These effects were not obtained when a smaller dose of lobeline sulphate (2 mg.) was given combined with antacids (Rapp and Olen, 1955) .
The absence of side-effects might have been due to the smallness of the dose, but Rapp et al. (1959) claimed that when such a preparation was given three times daily, blood: levels of up to 180 Ig. of lobeline per 100 ml. of blood were obtained. Unfortunately the exact details of the method of estimating the blood lobeline levels have not been published and this work has not to our knowledge been repeated.
The purpose of the present trial was to assess the value of such a preparation of lobeline as a deterrent of smoking. This preparation (" lobidan ") contains, in each tablet, lobeline sulphate 2 mg., magnesium carbonate 125 mg., and tribasic calcium phosphate 180 mg.
Method The trial was a co-operative one carried out at eleven chest clinics. The subjects selected were persons who regularly smoked 20 or more cigarettes a day and who wanted to give up smoking. Only those who smoked a registered brand of cigarettes-that is, no persons rolling their own cigarettes or pipe-smokers-were considered; they were not unduly coerced into joining the trial; they were normal subjects or patients suffering from chronic bronchitis and/or pulmonary fibrosis of tuberculous or other origin. The subjects were randomly allocated by the statistician to the lobidan or inert-tablet series; neither the subjects nor the clinic physicians were aware of the identity of the tablets.
The dose of either the lobidan or inert tablets was one tablet four times daily for six weeks. The inert tablets were identical to the lobidan in make-up and taste, but instead of 2 mg. of lobeline each tablet contained 15 mg. of quinine sulphate.
The subjects were asked to record on a form the number of cigarettes smoked in the week before the start of the trial and subsequently the number of cigarettes smoked and the number of tablets taken each week for the first six weeks of the trial, during which time they had been instructed to take one tablet four times daily. At the end of the six-week period the forms were returned to the co-ordinator, who decided whether or not the particular subject should be regarded as a success or failure. If
